New York S 4587: Requires a New York state legend on all bell jar tickets sold in New York state

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 - This bill is not active in this session.

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S04587 Summary:

BILL NOS04587 

&nbsp

SAME ASSAME AS A05285

&nbsp

SPONSORMAYER

&nbsp

COSPNSRWEBB

&nbsp

MLTSPNSR

&nbsp

Amd §§6807 & 6810, Ed L (as proposed in S.36-A and A.2145-A); add §280-d, Pub Health L

&nbsp

Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Go to top S04587 Actions:

BILL NOS04587 

&nbsp

02/07/2025REFERRED TO RULES

03/04/2025ORDERED TO THIRD READING CAL.447

03/10/2025SUBSTITUTED BY A5285

&nbspA05285 AMEND= Reyes

&nbsp02/12/2025referred to higher education

&nbsp02/24/2025reported referred to rules

&nbsp02/25/2025reported 

&nbsp02/25/2025rules report cal.103

&nbsp02/25/2025ordered to third reading rules cal.103

&nbsp03/05/2025passed assembly

&nbsp03/05/2025delivered to senate

&nbsp03/05/2025REFERRED TO RULES

&nbsp03/10/2025SUBSTITUTED FOR S4587

&nbsp03/10/20253RD READING CAL.447

&nbsp03/10/2025PASSED SENATE

&nbsp03/10/2025RETURNED TO ASSEMBLY

&nbsp03/20/2025delivered to governor

&nbsp03/20/2025signed chap.108

Go to topS04587 Committee&nbspVotes:

Go to topS04587 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS04587 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 4587

 2025-2026 Regular Sessions

 IN SENATE

 February 7, 2025
 ___________

 Introduced by Sen. MAYER -- read twice and ordered printed, and when
 printed to be committed to the Committee on Rules

 AN ACT to amend the education law and the public health law, in relation
 to prescription labels for mifepristone and misoprostol

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Paragraph b-1 of subdivision 1 of section 6807 of the
 2 education law, as added by a chapter of the laws of 2025 amending the
 3 education law relating to the labeling of mifepristone, misoprostol, and
 4 their generic alternatives, as proposed in legislative bills numbers S.
 5 36-A and A. 2145-A, is amended to read as follows:
 6 b-1. Notwithstanding paragraph b of this section, the prescription
 7 label for mifepristone[,] or misoprostol[, and their generic alterna-
 8 tives] may include the name or address of the dispensing health care
 9 practice instead of the name of the dispenser.
 10 § 2. Subdivision 1-a of section 6810 of the education law, as added by
 11 a chapter of the laws of 2025 amending the education law relating to the
 12 labeling of mifepristone, misoprostol, and their generic alternatives,
 13 as proposed in legislative bills numbers S. 36-A and A. 2145-A, is
 14 amended to read as follows:
 15 1-a. Notwithstanding subdivision one of this section, at the
 16 prescriber's request, the prescription label for mifepristone[,] or
 17 misoprostol[, and their generic alternatives may] shall include the name
 18 or address of the prescribing health care practice instead of the name
 19 of the prescriber.
 20 § 3. The public health law is amended by adding a new section 280-d to
 21 read as follows:
 22 § 280-d. Patient notification of prescription label change. A health
 23 care prescriber shall inform the patient if such prescriber has included
 24 or has requested to include the name or address of the prescribing

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09082-01-5

 S. 4587 2

 1 health care practice instead of the name of such prescriber on the
 2 prescription label when prescribing mifepristone or misoprostol.
 3 § 4. This act shall take effect on the same date and in the same
 4 manner as a chapter of the laws of 2025 amending the education law
 5 relating to the labeling of mifepristone, misoprostol, and their generic
 6 alternatives, as proposed in legislative bills numbers S. 36-A and A.
 7 2145-A, takes effect.